Akutbehandlung der Schizophrenie - OUCI
W Gaebel, Themenheft 50 „Schizophrenie“ · F Thibaut, Acute treatment of schizophrenia: introduction to the Word Federation of Societies of Biological Psychiatry ...
Akutbehandlung der Schizophrenie[![logo](/static/main/nav_logo.eefabe7874f9.png)](/en/)

- [Search](/en/)
- [Analytics](/en/stat/)
- [About](/en/about/)
- [![укр](/static/main/lang.b996e1fb2e0c.png)\
Українською](/works/4ba8Q6a7/)

# Akutbehandlung der Schizophrenie

[![](/static/main/ex_link.47510b0eb40d.png)\
https://doi.org/10.1055/a-2256-4976](https://doi.org/10.1055/a-2256-4976)


·
![](/static/main/open_access.2c9fa0286596.png)

**Journal:** Fortschritte der Neurologie · Psychiatrie, 2024, № 07/08, p. 310-326

**Publisher:**

Georg Thieme Verlag KG



**Authors:**




Aslihan Aksar,

Alkomiet Hasan




## List of references

01. W Gaebel, Themenheft 50 „Schizophrenie“



02. R Holzbach, Die Akutbehandlung der Schizophrenie, psychoneuro, № 29, с. 522


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1055/s-2003-44519](https://doi.org/10.1055/s-2003-44519)
03. A Hasan, Schizophrenia, Dtsch Ärztebl Int, № 117, с. 412


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.3238/arztebl.2020.0412](https://doi.org/10.3238/arztebl.2020.0412)
04. F Thibaut, Acute treatment of schizophrenia: introduction to the Word Federation of Societies of Biological Psychiatry guidelines, Psychiatr Danub, № 26, с. 2



05. M Huhn, Langzeittherapie der Schizophrenie, PSYCH up2date, № 16, с. 493


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1055/a-1239-5941](https://doi.org/10.1055/a-1239-5941)
06. Y Zhu, How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis, European Neuropsychopharmacology, № 27, с. 835


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1016/j.euroneuro.2017.06.011](https://doi.org/10.1016/j.euroneuro.2017.06.011)
07. S Leucht, Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors, Am J Psychiatry, № 174, с. 927


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1176/appi.ajp.2017.16121358](https://doi.org/10.1176/appi.ajp.2017.16121358)
08. C Oeser, Die Einführung der Antipsychotika an der Neurologisch-Psychiatrischen Klinik der Universität Leipzig und ihre Auswirkungen auf andere Therapieformen sowie auf die Verweildauern und Verlegungen, Nervenarzt, № 92, с. 69


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1007/s00115-020-00931-y](https://doi.org/10.1007/s00115-020-00931-y)
09. A Carlsson, Effect of Chlorpromazine or Haloperidol on Formation of 3-Methoxytyramine and Normetanephrine in Mouse Brain, Acta Pharmacol Toxicol (Copenh), № 20, с. 140


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1111/j.1600-0773.1963.tb01730.x](https://doi.org/10.1111/j.1600-0773.1963.tb01730.x)
10. A Farah, Atypicality of Atypical Antipsychotics, Prim Care Companion J Clin Psychiatry, № 7, с. 268


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.4088/PCC.v07n0602](https://doi.org/10.4088/PCC.v07n0602)
11. A Hasan, Erkennen und behandeln von Antipsychotika-Nebenwirkungen, InFo Neurologie, № 24, с. 43


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1007/s15005-022-2424-z](https://doi.org/10.1007/s15005-022-2424-z)
12. C U Correll, Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics, Schizophr, № 8, с. 5


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1038/s41537-021-00192-x](https://doi.org/10.1038/s41537-021-00192-x)
13. M Huhn, Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis, Lancet, № 394, с. 939


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1016/S0140-6736(19)31135-3](https://doi.org/10.1016/S0140-6736(19)31135-3)
14. S Leucht, Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network metaanalysis, World Psychiatry, № 22, с. 315


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1002/wps.21089](https://doi.org/10.1002/wps.21089)
15. J P Zhang, Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis, Int J Neuropsychopharmacol, № 16, с. 1205


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1017/S1461145712001277](https://doi.org/10.1017/S1461145712001277)
16. S Leucht, Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia, Am J Psychiatry, № 177, с. 342


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1176/appi.ajp.2019.19010034](https://doi.org/10.1176/appi.ajp.2019.19010034)
17. D M Gardner, International Consensus Study of Antipsychotic Dosing, Am J Psychiatry, № 167, с. 686


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1176/appi.ajp.2009.09060802](https://doi.org/10.1176/appi.ajp.2009.09060802)
18. H Takeuchi, Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis, Schizophr Bull, № 46, с. 1439


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1093/schbul/sbaa063](https://doi.org/10.1093/schbul/sbaa063)
19. W M Braude, Clinical Characteristics of Akathisia: A Systematic Investigation of Acute Psychiatric Inpatient Admissions, Br J Psychiatry, № 143, с. 139


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1192/bjp.143.2.139](https://doi.org/10.1192/bjp.143.2.139)
20. M J Müller, Antipsychotika. In: Benkert O, Hippius H (eds.) Kompendium der Psychiatrischen Pharmakotherapie, с. 269


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1007/978-3-662-50333-1\_3](https://doi.org/10.1007/978-3-662-50333-1_3)
21. S R Kay, The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Schizophr Bull, № 13, с. 261


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1093/schbul/13.2.261](https://doi.org/10.1093/schbul/13.2.261)
22. B Kinon, Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia, Schizophr Res, № 102, с. 230


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1016/j.schres.2008.02.021](https://doi.org/10.1016/j.schres.2008.02.021)
23. A Demjaha, Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors, Psychol Med, № 47, с. 1981


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1017/S0033291717000435](https://doi.org/10.1017/S0033291717000435)
24. D Siskind, Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis, Br J Psychiatry, № 220, с. 115


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1192/bjp.2021.61](https://doi.org/10.1192/bjp.2021.61)
25. J Bäuml, Psychoedukation bei schizophrenen Erkrankungen. Konsensuspapier der Arbeitsgruppe „Psychoeduaktion bei schizophrenen Erkrankungen“



26. V Mavandadi, Effective ingredients of verbal de-escalation: validating an English modified version of the ‘De-Escalating Aggressive Behaviour Scale’, J Psychiatr Ment Health Nurs, № 23, с. 357


    [![](/static/main/ex_link.47510b0eb40d.png)\
     https://doi.org/10.1111/jpm.12310](https://doi.org/10.1111/jpm.12310)
27. H J Möller, Duale Reihe Psychiatrie, Psychosomatik und Psychotherapie




**About this publication**Number of citations0Number of works in the list of references27Journal indexed in Scopus

Yes

Journal indexed in Web of Science

Yes



* * *

![Пошук](/static/main/spinner-big.e5e9172fc240.gif)